Dr. Bishop is a Professor of Pathology and Director of Head and Neck Pathology at UT Southwestern. A native Texan, Dr. Bishop grew up in Arlington, TX and received his undergraduate and medical degrees at Texas Tech University in Lubbock, Texas. He completed his pathology residency at The Johns Hopkins Hospital in Baltimore and received training head and neck pathology with Dr. William Westra. Dr. Bishop served as faculty at Johns Hopkins, where he reached the rank of associate professor and was the Director of the Immunohistochemistry laboratory and associate director of the head and neck pathology consult practice.

Dr. Bishop is an expert in the surgical pathology diagnosis of head and neck and endocrine diseases. He has published 175 journal articles, 19 book chapters, and 5 books, and lectured extensively both nationally and internationally. Dr. Bishop contributed 15 chapters to the most recent WHO Classification of Head and Neck Tumors, and will be the lead author of the upcoming AFIP Fascicle of Salivary Gland Tumors. He is an associate editor for Histopathology and JAMA Otolaryngology-Head and Neck Surgery, and a member of the editorial boards of American Journal of Surgical Pathology, Oral Oncology, and Annals of Otology and Rhinology, & Laryngology.

Dr. Dickson completed his undergraduate and graduate studies at Dalhousie University, followed by medical school and residency training at the University of Toronto. After a fellowship in Soft Tissue and Bone Pathology at the University of Pennsylvania, he returned to Toronto where he specializes in Sarcoma Pathology. He is a pathologist and director of Immunohistochemistry in the Department of Pathology and Laboratory Medicine at Mount Sinai Hospital, and associate professor in the Department of Laboratory Medicine and Pathobiology at the University of Toronto. His research is focused on developing novel diagnostic and prognostic markers in sarcoma, and elucidating the mechanisms of sarcomagenesis. Dr. Dickson also has an avid interest in teaching, which includes undergraduate students, residents and fellows, as well as an international audience via social media.

Elan Hahn is a clinical fellow in Head and Neck pathology at UHN. He is a recent graduate of the Anatomical Pathology program at the University of Toronto. He will be pursuing training in molecular genetic pathology at the University of Washington in 2022. He has an interest in tumours of the head and neck, along with their molecular underpinnings, as well as in cancer predisposition in general

Iona Leong is an oral pathologist and associate professor at the Faculty of Dentistry, University of Toronto, and at Mount Sinai Hospital. She received her B.Sc., B.Sc. Hons and B.D.S. degrees from the University of the Witwatersrand, South Africa, and her diploma and M.Sc. in Oral Pathology from the University of Toronto. She has been active in academic and clinical oral pathology and oral medicine since 1998. In addition to her major teaching role in the oral pathology and oral medicine residency training program, she teaches undergraduate dental students, other dental specialty residents and medical specialty residents.

She has developed and implemented continuing education programs for dentists and dental specialists since 2017. She maintains a practice limited to clinical oral pathology and oral medicine in the Department of Dentistry, Mount Sinai Hospital, where she is head of the Division of Oral Pathology and Oral Medicine. She is also an associate staff pathologist in the Department of Pathology and Laboratory Medicine, Mount Sinai Hospital and the Department of Pathobiology and Laboratory Medicine, University of Toronto. She served as the Chief Examiner in Oral Pathology and Oral Medicine from 2013 – 2018 and is currently the Board Director for Oral Pathology and Oral Medicine at the Royal College of Dentists of Canada.

I am a new addition to the cytopathology team at University Health Network. I am passionate about educating practicing pathologists and trainees on the wonders of cytopathology. My research interest include application and expanding the role of ancillary tests on cytologic specimens.

I received my medical degree from the University of Toronto in 1986 and completed the Anatomical Pathology Residency Program also at the University of Toronto in 1992. My first 10 years in practice was at the Toronto General Hospital, and University Health Network including the Princess Margaret Hospital. I completed my Head and Neck Pathology Fellowship in Pittsburgh, UPMC (1994-1995). I then moved to the Mount Sinai Hospital in Toronto in 2002, where I still currently practice. I am an assistant professor in the Department of Laboratory Medicine and Pathobiology, University of Toronto and a clinician-scientist who collaborates with the Head and Neck/Thyroid Research Program at Mount Sinai Hospital. Our primary focus is on the discovery of predictive biomarkers and utilization of molecular testing to advance diagnosis in thyroid fine needle aspiration cytology and cancers of the thyroid and head & neck. I am the co-director of the Alex and Simona Schnaider Research Laboratory in Molecular Oncology in the Department of Pathology and Laboratory Medicine, Mount Sinai Hospital and the Lunenfeld-Tanenbaum Research Institute

Ozgur Mete, MD, FRCPC is a Consultant Endocrine Pathologist at the University Health Network, and Professor in the Department of Laboratory Medicine and Pathobiology at the University of Toronto.

As a Clinician Investigator, Dr. Mete’s research focusses on the translation of basic findings to clinical tests that provide diagnostic, prognostic, and predictive biomarkers for endocrine tumors. His other interests involve development of practice guidelines, digital pathology, and innovative teaching designs.

In 2013, Dr. Mete received the Danny Ghazarian Resident Teaching Award, and in 2014 and 2017 the prestigious Wightman-Berris Academy Award for excellence in undergraduate and postgraduate medical teaching at the University of Toronto. In 2018, Dr. Mete received the teaching excellence award of the MD program at the University of Toronto as well as the undergraduate teaching award of the Laboratory Medicine and Pathobiology at the University of Toronto. Dr Mete is currently the Anatomic Pathology Residency Site Director at the University Health Network.

Dr. Mete has lectured in many international meetings, has co-edited 4 pathology textbooks, and authored over 140 textbook chapters, and more than 215 peer-reviewed journal articles in endocrine pathology. Dr Mete served as a leading author in several chapters for the 4th and 5th editions of the WHO classification of endocrine and neuroendocrine tumors, and he has been actively involved in endocrine chapters in the 5th series of the WHO central nervous system, pediatric, genitourinary, and head & neck bluebooks. In addition, Dr Mete has been appointed as one of the international disease-expert editors for the 5th series of the WHO endocrine and neuroendocrine, and the WHO head & neck bluebooks.

Dr. Mete is currently the Editor-in-Chief of Endocrine Pathology Journal and has been the President of Endocrine Pathology Society (2020-2022). Dr Mete is also a member of the College of American Pathologists (CAP)’s Cancer Committee and has been appointed to lead the CAP endocrine tumor protocols since 2019.

Dr. Miller-Monthrope is an academic Dermatologist and Dermatopathologist. She completed medical school, and residency training in both dermatology and anatomical pathology at the University of Toronto. After completing her first residency in dermatology, she practiced medical dermatology at Women’s College Hospital while completing a Master’s degree in Education. Dr. Miller Monthrope has special interests in curriculum development, resident education, clinical-pathological correlation, inflammatory dermatoses and diverse skin types. She currently splits her time between her medical dermatology practice at Women’s College Hospital and her dermatopathology practice at Unity Health (St. Michael’s Hospital & St. Joseph’s Health Centre). At all sites she is involved in medical student and residency education. Dr. Miller-Monthrope is also a busy mom of three small kids.

Dr. Schwock is staff cytopathologist at the University Health Network, Toronto, and Assistant Professor in the Department of Laboratory Medicine and Pathobiology at the University of Toronto. Dr. Schwock completed his Dr med degree at the University of Leipzig in Germany and a PhD at the University of Toronto. He obtained RCPSC certification in Anatomical Pathology and DRCPSC status in Cytopathology. Currently, Dr Schwock serves as vice-chair of the RCPSC Area of Focused Competence (AFC) Cytopathology Committee and as co-director of the AFC Cytopathology Fellowship at the University of Toronto. His interests involve the application of molecular pathology and biomarker testing to cytology specimens as well as cytopathology training and education.

Dr. Sheffield is an anatomic and molecular pathologist with the William Osler Health System in Brampton, Ontario. One of his main interests is the delivery of biomarker results to support precision oncology treatment. Dr. Sheffield has been a leader in the development and practice of community-based IHC and molecular biomarker testing in support of community cancer care

I am a staff pathologist at Mount Sinai Hospital Department of Pathology and Laboratory Medicine. I’m an Assistant Professor at Department of Laboratory Medicine and Pathobiology, University of Toronto.